Class III
Ongoing
Abilify (aripiprazole), 5 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-007-13
This recall is currently active, issued May 1, 2024. It was issued by Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd..
- Recall Initiated
- April 9, 2024
- Posted
- May 1, 2024
- Recall Number
- D-0466-2024
- Voluntary / Mandated
- Voluntary: Firm initiated
- Quantity
- 108,192/30 count bottles or 7 count blister packs
- Firm Location
- Tokushima, Japan
- Official Source
- View on FDA website ↗
Reason for Recall
Cross Contamination with Other Products
Distribution
USA nationwide.
Lot / Code Info
Lot # AKS00623A, Exp 01/31/2026; AKS00322A, Exp 02/28/2025
Other recent Class III Drug recalls
Eptifibatide Injection, 75 mg/100 mL vial for weight-adjusted bolus dosing, 1x100 mL Single-dose Via...
Slate Run Pharmaceuticals
· Mar 4, 2026
Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceutica...
Unichem Pharmaceuticals Usa Inc.
· Feb 18, 2026
parodontax (cetylpyridinium chloride)ACTIVE GUM HEALTH, Mouthwash, Mint. Net Wt 16.9 FL OZ (500 mL),...
Haleon Us Holdings Llc
· Feb 4, 2026
Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceutic...
Novadoz Pharmaceuticals Llc
· Feb 4, 2026
Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd.,...
Cipla Usa, Inc.
· Jan 28, 2026